Pharming Group reports financial results for the first quarter of 2022
Financial updatesPharming Group N.V. presents its (unaudited) financial report for the first quarter of the year ended 31 March 2022.
Pharming Group Notice of Q1 2022 Results
Financial updatesPharming confirms it will announce financial results for the first quarter of the year ended 31 March 2022 on Thursday, 12 May 2022.
Pharming announces change in its holding in BioConnection following a substantial investment by new investor
Financial updatesFollowing an agreed investment by European investment company Gimv, Pharming’s minority stake of 43.85% in BioConnection will reduce to 22.98%. As a result of this transaction, Pharming will receive one-off US$ 7.5 million (EUR 6.9 million) net cash proceeds.
Pharming Group reports financial results for full year 2021
Financial updatesPharming Group presents its preliminary financial report for the full year ended December 31, 2021.
Pharming Group reports financial results for the first nine months of 2021
Financial updatesPharming Group presents its preliminary (unaudited) financial report for the first nine months ended September 30, 2021.
Pharming Group Notice of 9M Results
Financial updates
Pharming Group reports financial results for the first half of 2021
Financial updatesRecovery continued into Q2 2021 as patient enrollment and product demand increases
Pharming Reports on Annual General Meeting of Shareholders
Financial updates
Pharming Group reports financial results for the first quarter of 2021
Financial updatesPharming Group N.V. presents its (unaudited) financial report for the first quarter of the year ended 31 March 2021.
Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
Financial updatesPharming Group announces the filing of its Annual Report on Form 20-F for the year ended 31 December 2020 with the U.S. Securities and Exchange Commission (SEC)